questionsmedicales.fr
États, signes et symptômes pathologiques
Signes et symptômes
Manifestations neurologiques
Paralysie
Ophtalmoplégie
Ophtalmoplégie externe progressive
Syndrome de Kearns-Sayre
Syndrome de Kearns-Sayre : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Syndrome de Kearns-Sayre : Questions médicales les plus fréquentes",
"headline": "Syndrome de Kearns-Sayre : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Syndrome de Kearns-Sayre : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-22",
"dateModified": "2025-02-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Syndrome de Kearns-Sayre"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Ophtalmoplégie externe progressive",
"url": "https://questionsmedicales.fr/mesh/D017246",
"about": {
"@type": "MedicalCondition",
"name": "Ophtalmoplégie externe progressive",
"code": {
"@type": "MedicalCode",
"code": "D017246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.888.592.636.447.511"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Syndrome de Kearns-Sayre",
"alternateName": "Kearns-Sayre Syndrome",
"code": {
"@type": "MedicalCode",
"code": "D007625",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Diego Martinelli",
"url": "https://questionsmedicales.fr/author/Diego%20Martinelli",
"affiliation": {
"@type": "Organization",
"name": "Division of Metabolism, IRCCS Bambino Gesù Children's Hospital, 00165, Rome, Italy."
}
},
{
"@type": "Person",
"name": "Glen Lester Sequiera",
"url": "https://questionsmedicales.fr/author/Glen%20Lester%20Sequiera",
"affiliation": {
"@type": "Organization",
"name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada."
}
},
{
"@type": "Person",
"name": "Abhay Srivastava",
"url": "https://questionsmedicales.fr/author/Abhay%20Srivastava",
"affiliation": {
"@type": "Organization",
"name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada."
}
},
{
"@type": "Person",
"name": "Keshav Narayan Alagarsamy",
"url": "https://questionsmedicales.fr/author/Keshav%20Narayan%20Alagarsamy",
"affiliation": {
"@type": "Organization",
"name": "St. Boniface Hospital Albrechtsen Research Centre, Regenerative Medicine Program, Department of Physiology and Pathophysiology, Rady Faculty of Health Sciences, Institute of Cardiovascular Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R2H 2A6, Canada."
}
},
{
"@type": "Person",
"name": "Cheryl Rockman-Greenberg",
"url": "https://questionsmedicales.fr/author/Cheryl%20Rockman-Greenberg",
"affiliation": {
"@type": "Organization",
"name": "Department of Pediatrics and Child Health, Rady Faculty of Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, MB R3E 3P4, Canada."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Application of Clustering-Based Analysis in MRI Brain Tissue Segmentation.",
"datePublished": "2022-08-03",
"url": "https://questionsmedicales.fr/article/35966247",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/7401184"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Classification of Fitness Components in Elite Alpine Skiers: A Cluster Analysis.",
"datePublished": "2023-05-17",
"url": "https://questionsmedicales.fr/article/37239567",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20105841"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cluster analysis of functional independence in community-dwelling older people.",
"datePublished": "2022-12-23",
"url": "https://questionsmedicales.fr/article/36564718",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12877-022-03684-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "K-mer applied in Mycobacterium tuberculosis genome cluster analysis.",
"datePublished": "2022-06-27",
"url": "https://questionsmedicales.fr/article/35766652",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1590/1519-6984.258258"
}
},
{
"@type": "ScholarlyArticle",
"name": "Power analysis for cluster randomized trials with continuous coprimary endpoints.",
"datePublished": "2022-05-23",
"url": "https://questionsmedicales.fr/article/35531926",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/biom.13692"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Signes et symptômes",
"item": "https://questionsmedicales.fr/mesh/D012816"
},
{
"@type": "ListItem",
"position": 4,
"name": "Manifestations neurologiques",
"item": "https://questionsmedicales.fr/mesh/D009461"
},
{
"@type": "ListItem",
"position": 5,
"name": "Paralysie",
"item": "https://questionsmedicales.fr/mesh/D010243"
},
{
"@type": "ListItem",
"position": 6,
"name": "Ophtalmoplégie",
"item": "https://questionsmedicales.fr/mesh/D009886"
},
{
"@type": "ListItem",
"position": 7,
"name": "Ophtalmoplégie externe progressive",
"item": "https://questionsmedicales.fr/mesh/D017246"
},
{
"@type": "ListItem",
"position": 8,
"name": "Syndrome de Kearns-Sayre",
"item": "https://questionsmedicales.fr/mesh/D007625"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Syndrome de Kearns-Sayre - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Syndrome de Kearns-Sayre",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-14",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Syndrome de Kearns-Sayre",
"description": "Comment diagnostique-t-on le syndrome de Kearns-Sayre ?\nQuels tests génétiques sont utilisés ?\nQuels signes cliniques sont observés ?\nL'électrocardiogramme est-il utile ?\nLes biopsies musculaires sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Syndrome de Kearns-Sayre",
"description": "Quels sont les symptômes principaux ?\nLa fatigue est-elle un symptôme fréquent ?\nY a-t-il des problèmes de vision ?\nLes troubles de l'équilibre sont-ils possibles ?\nLes patients peuvent-ils avoir des douleurs musculaires ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Syndrome de Kearns-Sayre",
"description": "Peut-on prévenir le syndrome de Kearns-Sayre ?\nLes tests génétiques peuvent-ils aider ?\nLes conseils génétiques sont-ils utiles ?\nLes femmes enceintes doivent-elles être testées ?\nY a-t-il des recommandations pour les familles ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Syndrome de Kearns-Sayre",
"description": "Quel est le traitement principal du syndrome ?\nLes suppléments de coenzyme Q10 sont-ils utiles ?\nDes médicaments sont-ils prescrits pour la cardiomyopathie ?\nLa physiothérapie est-elle recommandée ?\nY a-t-il des traitements pour les troubles de la vision ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Syndrome de Kearns-Sayre",
"description": "Quelles sont les complications possibles ?\nLe syndrome peut-il affecter la qualité de vie ?\nY a-t-il un risque accru de diabète ?\nLes troubles de la mémoire sont-ils fréquents ?\nLes patients sont-ils à risque d'infections ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Syndrome de Kearns-Sayre",
"description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nL'âge d'apparition est-il variable ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLes mutations génétiques sont-elles héréditaires ?",
"url": "https://questionsmedicales.fr/mesh/D007625?mesh_terms=Cluster+Analysis&page=4#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on le syndrome de Kearns-Sayre ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'IRM et des tests génétiques."
}
},
{
"@type": "Question",
"name": "Quels tests génétiques sont utilisés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests pour détecter des mutations dans l'ADN mitochondrial sont effectués."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont observés ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ophtalmoplégie, troubles cardiaques et anomalies neurologiques sont typiques."
}
},
{
"@type": "Question",
"name": "L'électrocardiogramme est-il utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut montrer des anomalies cardiaques associées au syndrome."
}
},
{
"@type": "Question",
"name": "Les biopsies musculaires sont-elles nécessaires ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être réalisées pour détecter des anomalies mitochondriales."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ophtalmoplégie, cardiomyopathie, surdité et troubles neurologiques."
}
},
{
"@type": "Question",
"name": "La fatigue est-elle un symptôme fréquent ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fatigue chronique est courante chez les patients atteints."
}
},
{
"@type": "Question",
"name": "Y a-t-il des problèmes de vision ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles visuels comme la ptose et la rétinopathie peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les troubles de l'équilibre sont-ils possibles ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes d'équilibre et de coordination peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les patients peuvent-ils avoir des douleurs musculaires ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des douleurs musculaires et des crampes sont souvent rapportées."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le syndrome de Kearns-Sayre ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention, car c'est une maladie génétique."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier les porteurs et informer les familles."
}
},
{
"@type": "Question",
"name": "Les conseils génétiques sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident les familles à comprendre les risques de transmission."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être testées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Si des antécédents familiaux existent, un test peut être recommandé."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations pour les familles ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conseils sur la gestion des symptômes et le soutien psychologique."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal du syndrome ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement curatif, mais des soins symptomatiques sont offerts."
}
},
{
"@type": "Question",
"name": "Les suppléments de coenzyme Q10 sont-ils utiles ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent aider à améliorer la fonction mitochondriale."
}
},
{
"@type": "Question",
"name": "Des médicaments sont-ils prescrits pour la cardiomyopathie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des médicaments comme les bêtabloquants peuvent être utilisés."
}
},
{
"@type": "Question",
"name": "La physiothérapie est-elle recommandée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la physiothérapie peut aider à améliorer la force et la mobilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour les troubles de la vision ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des aides visuelles et des interventions chirurgicales peuvent être envisagées."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance cardiaque et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Le syndrome peut-il affecter la qualité de vie ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent gravement impacter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de diabète ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains patients peuvent développer un diabète de type 2."
}
},
{
"@type": "Question",
"name": "Les troubles de la mémoire sont-ils fréquents ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs et de la mémoire peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les patients sont-ils à risque d'infections ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une immunité affaiblie peut augmenter le risque d'infections."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque connus ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux de maladies mitochondriales sont un facteur de risque."
}
},
{
"@type": "Question",
"name": "Le sexe influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, le syndrome affecte les hommes et les femmes de manière égale."
}
},
{
"@type": "Question",
"name": "L'âge d'apparition est-il variable ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent apparaître entre l'enfance et l'âge adulte."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'y a pas de preuves solides sur l'influence environnementale."
}
},
{
"@type": "Question",
"name": "Les mutations génétiques sont-elles héréditaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les mutations peuvent être transmises par la mère à l'enfant."
}
}
]
}
]
}
The segmentation of brain tissue by MRI not only contributes to the study of the function and anatomical structure of the brain, but it also offers a theoretical foundation for the diagnosis and treat...
The current study is an exploratory, secondary data analysis of a selection of physiological and biomechanical fitness components used to assess elite alpine skiers. The present study will provide new...
The concept of Functional Independence (FI), defined as 'functioning physically safe and independent from other persons, within one's context", plays an important role in maintaining the functional ab...
One hundred fifty-three community-dwelling older persons were included for participation. Cluster analysis identified four distinctive clusters: (1) Performers - Well-informed; this subgroup is physic...
Community-dwelling older persons can be allocated to four distinct and clinically relevant subgroups based on their level of FI. This subgrouping provides insight into the complex holistic concept of ...
According to studies carried out, approximately 10 million people developed tuberculosis in 2018. Of this total, 1.5 million people died from the disease. To study the behavior of the genome sequences...
Pragmatic trials evaluating health care interventions often adopt cluster randomization due to scientific or logistical considerations. Systematic reviews have shown that coprimary endpoints are not u...
This article aims to analyze spatial and temporal patterns of maternal mortality in Brazil during the period 2010-2020 and identify related socioeconomic indicators. We conducted an ecological study o...
Although Kawasaki disease is commonly regarded as a single disease entity, variability in clinical manifestations and disease outcome has been recognised. We aimed to use a data-driven approach to ide...
We analysed clinical data from patients with Kawasaki disease diagnosed at Rady Children's Hospital (San Diego, CA, USA) between Jan 1, 2002, and June 30, 2022. Patients were grouped by hierarchical c...
Among 1016 patients with complete data in the final analysis, four subgroups were identified with distinct clinical features: (1) hepatobiliary involvement with elevated alanine transaminase, gamma-gl...
Our data-driven analysis provides insight into the heterogeneity of Kawasaki disease, and supports the existence of distinct subgroups with important implications for clinical management and research ...
US National Institutes of Health and the Irving and Francine Suknow Foundation....
To investigate verb fluency performance in individuals with Alzheimer's disease compared with healthy older adults by analyzing total correct responses, number of clusters, average cluster size, and n...
This is a case-control study of 39 healthy older adults and 29 older adults with a diagnosis of Alzheimer's disease. Verb fluency performance was analyzed in terms of total number of correct verbs ret...
Individuals with Alzheimer's disease showed significantly poorer performance than healthy controls in the number of switches and total number of correct verbs retrieved. The two groups did not differ ...
In this study, individuals with Alzheimer's disease showed impaired verb fluency, characterized by a reduced number of verbs retrieved and fewer transitions between verb categories. The findings sugge...
The study aims to examine the clustering of infant deaths in India and the relative contribution of infant death clustering after accounting for the socio-economic and biodemographic factors that expl...
To determine if a greater than expected number of cases (clustering) of uveal melanoma occurred within Ohio for any specific region or time period as compared to others....
Analysis of population database....
Ohio Cancer Incidence Surveillance System (OCISS) database (2000-2019) was accessed for the diagnosis of uveal melanoma using the International Classification of Disease for Oncology codes: C69.3 (cho...
Over the twenty-year period, the total number of uveal melanoma cases reported within Ohio were 1,617 with the overall age-adjusted annual incidence of 6.72 cases per million population (95% CI 6.30-7...
There is no evidence of geographic or temporal clustering of uveal melanoma within Ohio from 2000 to 2019....